Herantis Pharma Oyj (HEL: HRTIS)
Finland
· Delayed Price · Currency is EUR 1.485
0.00 (0.00%)
Aug 30, 2024, 2:49 PM EET
Herantis Pharma Oyj Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1.99 | 5.5 | 5.04 | 6.44 | 12.34 | 6.01 | Upgrade
|
| Short-Term Investments | 1.5 | 0.99 | 0.96 | 0.99 | 0.99 | 0.99 | Upgrade
|
| Cash & Short-Term Investments | 3.49 | 6.49 | 5.99 | 7.42 | 13.32 | 7 | Upgrade
|
| Cash Growth | -28.93% | 8.30% | -19.31% | -44.28% | 90.41% | 220.19% | Upgrade
|
| Other Receivables | 0.12 | 0.24 | 0.2 | 0.12 | 0.17 | 0.24 | Upgrade
|
| Receivables | 0.12 | 0.24 | 0.2 | 0.12 | 0.17 | 0.24 | Upgrade
|
| Prepaid Expenses | 0.04 | 0.02 | 0.04 | 0.06 | 0.04 | 0.02 | Upgrade
|
| Total Current Assets | 3.65 | 6.75 | 6.23 | 7.6 | 13.54 | 7.26 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.16 | 2.88 | 3.81 | Upgrade
|
| Total Assets | 3.65 | 6.75 | 6.23 | 7.76 | 16.42 | 11.07 | Upgrade
|
| Accounts Payable | 0.78 | 0.75 | 0.66 | 0.79 | 0.72 | 1.62 | Upgrade
|
| Accrued Expenses | 0.75 | 1.13 | 1.06 | 0.73 | 0.82 | 0.35 | Upgrade
|
| Current Portion of Long-Term Debt | 0.01 | 0 | 0.15 | 0.91 | 1.27 | 0.01 | Upgrade
|
| Current Portion of Leases | - | 0.04 | - | 0.13 | - | - | Upgrade
|
| Other Current Liabilities | 0.04 | 0.06 | 0.03 | 0.05 | 0.09 | 0.03 | Upgrade
|
| Total Current Liabilities | 1.58 | 1.99 | 1.9 | 2.61 | 2.89 | 2.01 | Upgrade
|
| Long-Term Debt | 0.03 | 0.03 | 4.39 | 6.29 | 5.94 | 7.21 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | - | - | Upgrade
|
| Total Liabilities | 1.61 | 2.02 | 6.29 | 8.9 | 8.83 | 9.22 | Upgrade
|
| Common Stock | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Retained Earnings | -77.79 | -75.1 | -75.38 | -67.75 | -54.98 | -45.83 | Upgrade
|
| Comprensive Income & Other | 79.75 | 79.75 | 75.24 | 66.53 | 62.49 | 47.6 | Upgrade
|
| Shareholders' Equity | 2.04 | 4.73 | -0.06 | -1.14 | 7.59 | 1.85 | Upgrade
|
| Total Liabilities & Equity | 3.65 | 6.75 | 6.23 | 7.76 | 16.42 | 11.07 | Upgrade
|
| Total Debt | 0.03 | 0.08 | 4.54 | 7.33 | 7.21 | 7.21 | Upgrade
|
| Net Cash (Debt) | 3.46 | 6.41 | 1.45 | 0.09 | 6.12 | -0.21 | Upgrade
|
| Net Cash Growth | 839.95% | 342.20% | 1482.98% | -98.50% | - | - | Upgrade
|
| Net Cash Per Share | 0.18 | 0.37 | 0.10 | 0.01 | 0.83 | -0.04 | Upgrade
|
| Filing Date Shares Outstanding | 20.16 | 20.16 | 16.91 | 11.1 | 9.76 | 6.68 | Upgrade
|
| Total Common Shares Outstanding | 20.16 | 20.16 | 16.91 | 11.1 | 9.76 | 6.68 | Upgrade
|
| Working Capital | 2.07 | 4.76 | 4.33 | 4.99 | 10.65 | 5.25 | Upgrade
|
| Book Value Per Share | 0.10 | 0.23 | -0.00 | -0.10 | 0.78 | 0.28 | Upgrade
|
| Tangible Book Value | 2.04 | 4.73 | -0.06 | -1.14 | 7.59 | 1.85 | Upgrade
|
| Tangible Book Value Per Share | 0.10 | 0.23 | -0.00 | -0.10 | 0.78 | 0.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.